Home › Funds › Point72 Asset Management › BBIO
Point72 Asset Management position in BBIO
BRIDGEBIO PHARMA INC · Health Care
Latest position (Q2 2026)1.53M sh
Reported value held$114.16M
Portfolio Weight0.13%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 133.21K | $2.22M | New |
| Q1 2022 | 4.00M | $1.92M | Add |
| Q2 2022 | 4.00M | $1.60M | Hold |
| Q3 2022 | 4.00M | $1.69M | Hold |
| Q4 2022 | 4.00M | $1.53M | Hold |
| Q1 2023 | 134.17K | $2.22M | Reduce |
| Q2 2023 | 66.67K | $1.15M | Reduce |
| Q3 2023 | 5.26K | $138.84K | Reduce |
| Q4 2023 | 50.00K | $2.02M | Add |
| Q1 2024 | 14.50M | $15.60M | Add |
| Q2 2024 | 30.00K | $759.90K | Reduce |
| Q3 2024 | 35.00K | $891.10K | Add |
| Q4 2024 | 60.00K | $1.65M | Add |
| Q1 2025 | 328.78K | $11.37M | Add |
| Q4 2025 | 7.60K | $581.32K | New |
| Q1 2026 | 47.20K | $3.51M | Add |
| Q2 2026 | 1.53M | $114.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBIO
- Vanguard Group 16.86M sh · $1.29B · Q4 2025
- Janus Henderson Group 13.18M sh · $978.61M · Q1 2026
- Farallon Capital Management 10.74M sh · $800.14M · Q2 2026
- Viking Global Investors 9.95M sh · $741.02M · Q2 2026
- Two Sigma Investments 4.75M sh · $353.43M · Q2 2026
- D. E. Shaw & Co 3.66M sh · $272.89M · Q2 2026
- Geode Capital Management 3.42M sh · $254.67M · Q2 2026
- Manulife Financial 1.96M sh · $145.66M · Q2 2026
- Charles Schwab Investment Management 1.71M sh · $127.32M · Q2 2026
- Norges Bank Investment Management 1.69M sh · $126.15M · Q2 2026
- Morgan Stanley 1.69M sh · $126.14M · Q2 2026